Page 10 - சான்ஃபோர்ட் பர்ன்ஹாம் பிரேபய்ச் மருத்துவ கண்டுபிடிப்பு நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stem Cell Alopecia Treatment Market 2021 Size, Share, Recent Demand, Trends, Development, Revenue and Forecast to 2026 Says Absolute Reports
wfmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wfmj.com Daily Mail and Mail on Sunday newspapers.
Ralph Brandenberger,
Ph.D., to senior vice president, technical operations. Brandenberger joined the Nkarta team in 2018 and oversees the company s cell therapy manufacturing operations.
> Asklepios Biopharmaceutical tapped
Tracy Dowling as general counsel starting Jan. 25. Dowling will help manage and advise on corporate governance, business development transactions, license agreements, employment law and more. Most recently, Dowling served as associate general counsel at Spark Therapeutics.
> Precision oncology specialist OncoDNA signed on
Bernard Courtieu as CEO. Courtieu previously joined IntegraGen as CEO in 2007.
Eduardo Bravo,
OncoDNA s interim CEO since July 2020, will remain a consultant to the company s board.
> Abingdon Health named
Melanie Ross as chief financial officer, effective immediately. Ross will also serve on the company s board. Most recently, she was group finance director at GVO-B1; prior to that, Ross was chief financial office
New York Tech researchers receive NIH grant to improve the understanding of atherosclerosis
A New York Institute of Technology research team led by Olga V. Savinova, Ph.D., assistant professor of biomedical sciences at New York Institute of Technology College of Osteopathic Medicine (NYITCOM), has secured a five-year grant from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute. The $1.8 million grant, which includes a first-year award of $342,675, will support research to improve the understanding of atherosclerosis (hardening of the arteries) and deliver a new treatment for heart disease.
According to the Centers for Disease Control and Prevention, more than 30 million U.S. adults have been diagnosed with heart disease, which also causes one in every four deaths. Researchers have long believed that atherosclerosis is a risk factor in predicting heart disease-related illness and death. The buildup of calcium salts in blood vessel tissue, known as vas
Press release content from PR Newswire. The AP news staff was not involved in its creation.
New York Tech Research Team Secures $1.8M NIH Grant to Investigate Vascular Decalcification as Heart Disease Treatment
January 27, 2021 GMT
OLD WESTBURY, N.Y., Jan. 27, 2021 /PRNewswire/ A New York Institute of Technology research team led by Olga V. Savinova, Ph.D., assistant professor of biomedical sciences at New York Institute of Technology College of Osteopathic Medicine (NYITCOM), has secured a five-year grant from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute. The $1.8 million grant, which includes a first-year award of $342,675, will support research to improve the understanding of atherosclerosis (hardening of the arteries) and deliver a new treatment for heart disease.
Vascular Decalcification as Heart Disease Treatment Examined in $1.8 Million NIH Grant
New York Tech research team uses computational models to map the blood flow impact of increased calcification
Heavily calcified coronary arteries seen on a CT scan of the heart. Research at the New York Institute of Technology will create blood flow modeling to show the impact of calcium in arteries as part of a project to develop treatments to remove calcium.
January 27, 2021 A New York Institute of Technology research team has secured a five-year $1.8 million grant from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute for research to improve the understanding of atherosclerosis and deliver a new treatment for heart disease.
vimarsana © 2020. All Rights Reserved.